... 2000) A diagnosis of parental breast cancer in the family adds another significant stressor for the young adult child The difficulties that families experience in communicating about breast cancer ... boundaries around the information they consider to be their own In the case of parents who are diagnosed with breast cancer, they may feel a sense of ownership about their breast cancer diagnosis, prognosis, ... of Breast Cancer and Changes in Family Privacy This transition to college becomes considerably more complicated when the young adult‟s parent is diagnosed with breast cancer The diagnosis of breast...
Ngày tải lên: 24/08/2014, 10:52
... disease and cancer It therefore no longer seems reasonable to attend for breast cancer screening In fact, by avoiding going to screening, a woman will lower her risk of getting a breast cancer diagnosis ... reducing the risk of dying from breast cancer Screening produces patients with breast cancer from among healthy women who would never have developed symptoms of breast cancer Treatment of these healthy ... Trang 1SCREENING FOR BREAST CANCER WITH MAMMOGRAPHY What are the benefits and harms of attending a screening programme for breast cancer? How many will benefit from being...
Ngày tải lên: 15/02/2014, 05:20
Early and locally advanced breast cancer: diagnosis and treatment pdf
... breast cancer guideline • Docetaxel for the treatment of early breast cancer NICE single technology appraisal (Publication expected July 2006) • Paclitaxel for the treatment of early breast cancer ... advanced breast cancer: diagnosis and treatment Information Specialists Sabine Berendse National Collaborating Centre for Cancer, Cardiff Elise Collins National Collaborating Centre for Cancer, ... including cancer patients It is a time-limited, structured and direct form of therapy that is well suited to patients with breast cancer Unfortunately there are no studies that compare CBT in breast cancer...
Ngày tải lên: 22/03/2014, 16:21
Báo cáo sinh học: " Encapsulation of docetaxel in oily core polyester nanocapsule intended for breast cancer therapy" pptx
... nanocapsule form This observation was consistent with a previous report [48] related to a nanoparticulate form of another anticancer drug (doxorubicin) tested on a different breast cancer cell ... characterized for particle size, zeta potential, EE%, drug release kinetics, morphology, crystallinity, and cytotoxicity on the SUM 225 breast cancer cell line by dynamic light scattering, high performance ... NCs The NCs' mean diameters were 127.5 ± 19.2 nm for NC-PLA206, 123.8 ± 0.9 nm for NC-PLA207, 110.8 ± 8.6 nm for NC-PLA208, and 124.6 ± 3.1 nm for NC-PCL These findings indicated a statistically...
Ngày tải lên: 18/06/2014, 22:20
Báo cáo hóa học: " A Novel Docetaxel-Loaded Poly (e-Caprolactone)/Pluronic F68 Nanoparticle Overcoming Multidrug Resistance for Breast Cancer Treatment" pot
... human breast cancer cells and therefore have considerable potential for treatment of breast cancer Keywords Nanoparticles MDR Pluronic F68 Poly (e-caprolactone) Docetaxel Breast cancer ... commonly used in the treatment of breast cancer, oval cancer, small and nonsmall cell lung cancer, prostate cancer, etc Its commercial formulation TaxotereÒ is formulated in high concentration ... multidrug resistance in human breast cancer cells and therefore have considerable potential for treatment of breast cancer Acknowledgments The authors are grateful for financial support from the...
Ngày tải lên: 22/06/2014, 00:20
báo cáo khoa học: "Free Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy" docx
... AccessFree Rhodium (II) citrate and rhodium (II) citrate magnetic carriers as potential strategies for breast cancer therapy Marcella LB Carneiro1*†, Eloiza S Nunes2, Raphael CA Peixoto1, Ricardo GS Oliveira1, ... promising agent for chemotherapy Nevertheless, few studies have been performed to explore this potential Superparamagnetic particles of iron oxide (SPIOs) represent an attractive platform as carriers ... on breast carcinoma cells than on breast normal cells, which is the opposite of the results observed with free Rh2(H2cit)4treatment Thus, magnetic nanoparticles represent an attractive platform...
Ngày tải lên: 11/08/2014, 00:23
Liposomal co encapsulation of quercetin with synergistic chemotherapeutic drugs for breast cancer treatment
... treatment regimens for breast cancer remain unsatisfactory The relapse rate for breast cancer patients is 85% (Bernard-Marty, Cardoso et al 2004) This highlights the Trang 24need for the continued ... range of cancers such as colon cancer (van der Woude, Gliszczynska-Swiglo et al 2003), breast cancer (Hakimuddin, Paliyath et al 2004), ovarian cancer (Ferry, Smith et al 1996), prostate cancer ... especially for breast cancers that do not express estrogen, progesterone and HER2 receptors In addition, chemotherapy is not only given for the treatment of systemic disease, it can also be given before...
Ngày tải lên: 11/09/2015, 10:07
Radiation therapy techniques and treatment planning for breast cancer
... delineation for elective radiation therapy of early stage breast cancer Radiother Oncol 114:3–10 21 Moran MS, Haffty BG (2009) Radiation techniques and toxicities for locally advanced breast cancer ... the treated breast, toward the treated breast, or in a neutral position depending on the style of prone breast board and individual patient comfort (Fig 1.1c, d ) The ipsilateral breast falls ... the breast for a supine patient ( b ) DVH showing tumor bed coverage as well as heart and lung doses for the same supine patient ( c ) Axial CT image demonstrating dose coverage of the breast for...
Ngày tải lên: 14/05/2018, 13:25
Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase
... candidates for anticancer drugs [21] Tetran-drine and fangchinoline belong to bisbenzylisoquinoline alkaloids In this paper, potential antiproliferative small molecules for breast cancer were ... inhibiting MDA-MB-435 breast cancer cells expansion MTT method We seeded MDA-MB-435 breast cancer cells into 96-well plate at the density of 8 × 103each well and cultured for 12 h when they were ... colony forming assay found that HJNO also had a strong inhibitory effect on the colony formation of MDA-MB-435 breast cancer cells The mRNA and protein expression of BLM helicase in MDA-MB-435 breast...
Ngày tải lên: 17/06/2020, 18:15
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: A retrospective study
... advanced breast cancer, especially for patients with large tumor size, lymph node metasta-sis, HER2 overexpression, triple negative breast cancer (TNBC) subtype, or inflammatory breast cancer The ... in breast cancer patients undergoing NAC Keywords: Vitamin D, Neo-adjuvant breast cancer, pCR Background Neoadjuvant chemotherapy (NAC) has become a stand-ard of care in locally advanced breast ... (NAC) for operable breast cancer We report the impact of VD on pCR and survival in an expanded cohort Methods: Patients from Iowa and Montpellier registries who had serum VD level measured before...
Ngày tải lên: 03/07/2020, 01:26
Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
... lymphocytes, RCB residual cancer burden, TNBC triple-negative breast cancer, HER2BC human epidermal growth factor receptor 2-enriched breast cancer, HRBC hormone receptor-positive breast cancer, pCR pathological ... curve analyses in all breast cancer and TNBC patients ROC analysis showed that, for all breast cancer patients, the results for the RCB-TILs (AUC: 0.700) were better than those for the TILs (AUC: ... neoadjuvant therapy for breast cancer Breast Cancer Res 2007;9(5):110. 4 Sachelarie I, Grossbard ML, Chadha M, Feldman S, Ghesani M, Blum RH Primary systemic therapy of breast cancer Oncologist...
Ngày tải lên: 23/07/2020, 23:58
Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: A systematic review
... 2With improvements in early detection, diagnosis, and treatment of breast cancer, as well as an increase in breast cancer incidence, the number of breast cancer survivors is growing [1] It is ... (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review Abstract Background: Breast cancer related lymphedema (BCRL) is a prevalent complication secondary to cancer treatments ... encouraging, a considerable number of breast cancer survivors suffer from secondary lymph-edema due to cancer related treatments (surgery and/or radiation therapy) Despite efforts to reduce lymph-edema...
Ngày tải lên: 06/08/2020, 03:41
Evaluation of MiR-1908-3p as a novel serum biomarker for breast cancer and analysis its oncogenic function and target genes
... progress of breast cancer is essential to improve the diagnosis and treatment of breast cancer Previous research indicated that numerous miRNAs are involved in the progress of breast cancer [2–7] ... MiR-1908-3p is highly expressed in breast cancer tissues and breast cancer cells a The miR-1908-3p expression level in breast cancer tissues and adjacent normal breast tissues were compared using ... of tumor, including breast cancer Therefore, miR-1908-3p may target these eight genes to faciliate the progress of breast cancer and decrease the survival time of breast cancer patients Fig 7...
Ngày tải lên: 06/08/2020, 05:32
Breast cancer diagnosis is associated with relative left ventricular hypertrophy and elevated endothelin-1 signaling
... survival rates of women with breast cancer have improved significantly over the last four decades due to advances in breast cancer early diagnosis and therapy However, breast cancer survivors have an ... patients with breast cancer and their healthy controls BSA, BMI and health history for the patients with breast cancer and a control cohort of women are shown in Table1 While breast cancer patients ... advanced stages of breast cancer Discussion In an interesting and exciting new discovery, we show that even prior to systemic therapy for breast cancer, patients diagnosed with breast cancer exhibit...
Ngày tải lên: 19/09/2020, 22:01
Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients
... and mortality rate of breast cancer are still raising [1] In 2013, breast can-cer accounted for 25 % of total cancan-cer cases and 15 % of cancer-related deaths worldwide [1] For decades, surgi-cal ... Domain Dedication waiver Trang 2Breast cancer is the most frequently diagnosed cancer among females worldwide [1] In more developed coun-tries like the U.S., breast cancer death rates have slowly ... used in this study Formalin fixed, paraffin-embedded breast cancer tissue specimens from the above 238 patients were ob-tained from the Breast Center at Peking University Cancer Hospital &...
Ngày tải lên: 20/09/2020, 17:57
Validation of the CancerMath prognostic tool for breast cancer in Southeast Asia
... Background: CancerMath is a set of web-based prognostic tools which predict nodal status and survival up to 15 years after diagnosis of breast cancer This study validated its performance in a ... setting Methods: Using Singapore Malaysia Hospital-Based Breast Cancer Registry, clinical information was retrieved from 7064 stage I to III breast cancer patients who were diagnosed between 1990 and ... calibration of CancerMath were modest The results suggest that clinical application of CancerMath should be limited to patients with better prognostic profile Keywords: Breast cancer, CancerMath,...
Ngày tải lên: 20/09/2020, 18:20
The combination of blue dye and radioisotope versus radioisotope alone during sentinel lymph node biopsy for breast cancer: A systematic review
... rate Keywords: Breast cancer, Sentinel lymph node, Blue dye, Radioisotope, Systematic review Background The most important prognostic factor for patients with early-stage breast cancer was the ... dye and radioisotope outperformed radioisotope alone in SLN detection, the superiority for dual tracers may be limited for patients with positive lymphoscintigraphy or for those after neoadjuvant ... procedure for axillary staging in patients with clinically node-negative breast cancer [2, 3] SLNs were defined as the first lymph nodes that received lymphatic drainage from the primary cancer...
Ngày tải lên: 21/09/2020, 11:38
Physical activity before and after breast cancer diagnosis and survival - the Norwegian women and cancer cohort study
... in women with breast cancer [26] Study limitations include the absence of information on breast cancer treatment However, we did adjust for tumor stage at diagnosis In Norway, cancer treatment ... R, Abrahamson P, Stevens J, et al Post-diagnosis physical activity and survival after breast cancer diagnosis: the Long Island Breast Cancer Study Breast Cancer Res Treat 2014;145(3): 735 –42 ... active before breast cancer diagnosis reported lower PA levels after diagnosis It was beyond the scope of our study to inves-tigate the reasons for this decrease, but it reveals a potential for interventions...
Ngày tải lên: 22/09/2020, 23:02
Preliminary study on the effects of treatment for breast cancer: Immunological markers as they relate to quality of life and neuropsychological performance
... standard of care for breast cancer at that time Unfortunately, the molecular subtype of breast cancer (e.g., triple negative, HER2+, HR+) was not available for the active patient or breast cancer survivor ... beginning at diagnosis for early-stage breast cancer patients, and continuing through the course of treatment These interrelationships will be compared to those of a group of breast-cancer survivors ... at enrollment for active treatment breast cancer group and the breast cancer post-treatment (remission) comparison group not on active treatment, were compared using item averages for all questions...
Ngày tải lên: 23/09/2020, 01:22
Patient and physician factors associated with Oncotype DX and adjuvant chemotherapy utilization for breast cancer patients in New Hampshire, 2010-2016
... chemotherapy for breast cancer patients in New Hampshire Methods: We examined New Hampshire State Cancer Registry data on 5630 female breast cancer patients diagnosed from 2010 to 2016 We performed ... Institute for Health Policy and Clinical Practice, Lebanon, NH, USA Full list of author information is available at the end of the article Trang 2Breast cancer (BC) is the leading cause of cancer ... Chemotherapy was recommended for 2701 (48.0%) tients in the breast cancer cohort and 459 (30.4%) of pa-tients who received ODX In the unadjusted analyses, we found year of diagnosis, patient age,...
Ngày tải lên: 28/09/2020, 09:41